HCA Healthcare, Inc（HCA）の決算・業績分析
HCA Healthcare, Incの2025年有価証券報告書をAI分析。売上高$75.6B(+7.1%)。Health Care。
目次
HCA Healthcare, Incの2025年度 業績サマリー
HCA Healthcare, Inc（証券コード: HCA）の2025年度決算・業績分析。売上高は$75.6B（前年比+7.1%）。純利益は$6.8B（前年比+17.8%）。有価証券報告書を基に、業績変化の要因・リスク・見通し・セグメント構成を AI が分析しました。
HCA Healthcare, Incの2024年度 注目ポイント
※ 直近の2025年度XBRLデータは取込済みですが、AI分析は2024年度の10-Kを対象としています。
- Net Income declined 18.9% YoY to $5.6B (XBRL), despite Revenue growth of 2.5% to $60.2B (XBRL).
- Net Debt/EBITDA ratio stands at 3.1x (XBRL), reflecting high leverage with $37.2B in Long-Term Debt (XBRL).
- Share Repurchases totaled $7.0B (XBRL), offsetting Dividends Paid of $653M (XBRL) in FY2024.
HCA Healthcare, Incの売上高変化の要因
- •Revenue grew 2.5% YoY to $60.2B (XBRL), with a 5-year CAGR of 6.8% (XBRL). No segment-specific revenue data is available (XBRL). Growth is supported by expanded healthcare services and operational scale, though Net Income declined sharply (-18.9% YoY) due to rising debt costs and operational pressures (XBRL).
HCA Healthcare, Incの営業利益変化の要因
- •Operating Margin remained stable at 14.2% (XBRL), but Net Margin fell to 9.4% (XBRL), down from $7.0B Net Income in FY2023 (XBRL). EBITDA of $11.5B (19.2% margin) reflects strong core operations, though high interest expenses from $37.2B in Long-Term Debt (XBRL) pressured profitability (XBRL).
HCA Healthcare, Incの事業リスクと対応
High indebtedness ($43.031B) (10-K) limits flexibility and increases vulnerability to interest rate fluctuations.
Inability to refinance debt on favorable terms due to global financial conditions (10-K).
Debt covenant restrictions limit operational flexibility (10-K).
Insufficient cash flows to meet debt obligations may trigger liquidity crises (10-K).
Dependence on subsidiaries for debt repayment creates legal and financial risks (10-K).
HCA Healthcare, Incの事業内容
HCA Healthcare operates 190 hospitals and 124 ambulatory surgery centers, providing inpatient, outpatient, and diagnostic healthcare services (10-K). Revenue is generated through medical services, insurance reimbursements, and operations across diverse healthcare segments including behavioral hospitals, rehabilitation centers, and urgent care (10-K). Competitive advantages include clinical innovation, economies of scale, and partnerships, though no significant intellectual property is disclosed (10-K).
HCA Healthcare, IncのAI業績分析レポート（2024年度）
HCA Healthcare, Inc. FY2024 Annual Report Analysis
Highlights
Business Overview
HCA Healthcare operates 190 hospitals and 124 ambulatory surgery centers, providing inpatient, outpatient, and diagnostic healthcare services (10-K). Revenue is generated through medical services, insurance reimbursements, and operations across diverse healthcare segments including behavioral hospitals, rehabilitation centers, and urgent care (10-K). Competitive advantages include clinical innovation, economies of scale, and partnerships, though no significant intellectual property is disclosed (10-K).
Revenue Analysis
Revenue grew 2.5% YoY to $60.2B (XBRL), with a 5-year CAGR of 6.8% (XBRL). No segment-specific revenue data is available (XBRL). Growth is supported by expanded healthcare services and operational scale, though Net Income declined sharply (-18.9% YoY) due to rising debt costs and operational pressures (XBRL).
Profitability Analysis
Operating Margin remained stable at 14.2% (XBRL), but Net Margin fell to 9.4% (XBRL), down from $7.0B Net Income in FY2023 (XBRL). EBITDA of $11.5B (19.2% margin) reflects strong core operations, though high interest expenses from $37.2B in Long-Term Debt (XBRL) pressured profitability (XBRL).
Balance Sheet Analysis
Equity Ratio is negative at -3.4% (XBRL), with Total Equity at -$1.8B (XBRL). Current Ratio of 1.18x (XBRL) indicates moderate liquidity. Net Debt of $36.2B (3.1x EBITDA) (XBRL) highlights significant leverage, though Cash reserves stand at $935M (XBRL).
Cash Flow Analysis
Operating Cash Flow of $8.5B (XBRL) funded $4.1B Free Cash Flow (FCF) after $4.4B in CapEx (XBRL). Financing activities included $7.0B in Share Repurchases (XBRL) and $653M in Dividends (XBRL), despite $5.7B in net cash outflows (XBRL).
Working Capital Analysis
Cash Conversion Cycle (CCC) of 47 days (XBRL) reflects 60 days in Receivables, 12 days in Inventory, and 26 days in Payables (XBRL).
Risks
Outlook
N/A — No forward-looking guidance or management commentary is explicitly mentioned in the 10-K or XBRL data.
Health Careの企業一覧
HCA Healthcare, Incと同じ「Health Care」セクターの企業